Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa.

Pim AartsJ C van HuijsteeH H van der ZeeKelsey R van StraalenE P Prens

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)

Adalimumab initiated with clindamycin and rifampicin shows greater clinical effectiveness than adalimumab monotherapy. An important difference in effect was observed in the decrease of draining tunnels, addressing a serious limitation of adalimumab monotherapy.

Keyphrases

hidradenitis suppurativa
rheumatoid arthritis
juvenile idiopathic arthritis
randomized controlled trial
mycobacterium tuberculosis
systematic review
ulcerative colitis
combination therapy
open label
pulmonary tuberculosis
clinical trial